269 related articles for article (PubMed ID: 21051857)
41. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
[TBL] [Abstract][Full Text] [Related]
42. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
Miettinen PJ; Ebner R; Lopez AR; Derynck R
J Cell Biol; 1994 Dec; 127(6 Pt 2):2021-36. PubMed ID: 7806579
[TBL] [Abstract][Full Text] [Related]
43. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
44. Three-dimensional Mammary Epithelial Cell Morphogenesis Model for Analysis of TGFß Signaling.
Rashidian J; Luo K
Methods Mol Biol; 2016; 1344():121-35. PubMed ID: 26520121
[TBL] [Abstract][Full Text] [Related]
45. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
46. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.
Morrison CD; Allington TM; Thompson CL; Gilmore HL; Chang JC; Keri RA; Schiemann WP
Oncotarget; 2016 Nov; 7(45):72777-72794. PubMed ID: 27626309
[TBL] [Abstract][Full Text] [Related]
47. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
48. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
Serrano I; McDonald PC; Lock FE; Dedhar S
Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
[TBL] [Abstract][Full Text] [Related]
49. Dissimilar effects of LY 294002 and PD 098059 in IGF-I-mediated inhibition of TGF-beta1 expression and apoptosis in bovine mammary epithelial cells.
Zarzyńska J; Motyl T
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():181-93. PubMed ID: 16077202
[TBL] [Abstract][Full Text] [Related]
50. Dynamics of TGF-β induced epithelial-to-mesenchymal transition monitored by electric cell-substrate impedance sensing.
Schneider D; Tarantola M; Janshoff A
Biochim Biophys Acta; 2011 Dec; 1813(12):2099-107. PubMed ID: 21839117
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
52. The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells.
Llobet-Navas D; Rodriguez-Barrueco R; de la Iglesia-Vicente J; Olivan M; Castro V; Saucedo-Cuevas L; Marshall N; Putcha P; Castillo-Martin M; Bardot E; Ezhkova E; Iavarone A; Cordon-Cardo C; Silva JM
Mol Cell Biol; 2014 Dec; 34(23):4216-31. PubMed ID: 25266660
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line.
Xie L; Law BK; Aakre ME; Edgerton M; Shyr Y; Bhowmick NA; Moses HL
Breast Cancer Res; 2003; 5(6):R187-98. PubMed ID: 14580254
[TBL] [Abstract][Full Text] [Related]
54. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
Lee YH; Schiemann WP
Breast Cancer Manag; 2014; 3(1):73-85. PubMed ID: 25904986
[TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells.
Zhang Y; Liu T; Yan P; Huang T; Dewille J
BMC Mol Biol; 2008 Oct; 9():83. PubMed ID: 18828910
[TBL] [Abstract][Full Text] [Related]
57. p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β.
Termén S; Tan EJ; Heldin CH; Moustakas A
J Cell Physiol; 2013 Apr; 228(4):801-13. PubMed ID: 23018556
[TBL] [Abstract][Full Text] [Related]
58. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
[TBL] [Abstract][Full Text] [Related]
59. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R
PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585
[TBL] [Abstract][Full Text] [Related]
60. Opposing roles of TGF-β and EGF in the regulation of TRAIL-induced apoptosis in human breast epithelial cells.
Cano-González A; López-Rivas A
Biochim Biophys Acta; 2016 Aug; 1863(8):2104-14. PubMed ID: 27208428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
